These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21414623)

  • 21. Simvastatin decreases concentration of interleukin-2 in hypercholesterolemic patients after treatment for 12 weeks.
    Zubelewicz-Szkodzińska B; Szkodziński J; Romanowski W; Błazelonis A; Danikiewicz A; Muc-Wierzgoń M; Szkilnik R
    J Biol Regul Homeost Agents; 2004; 18(3-4):295-301. PubMed ID: 15786696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effect of lipid-lowering therapy on atherosclerosis of abdominal aorta in patients with hypercholesterolemia: noninvasive evaluation by a new image analysis program.
    Arai Y; Hirose N; Yamamura K; Kimura M; Murayama A; Fujii I; Tsushima M
    Angiology; 2002; 53(1):57-68. PubMed ID: 11863310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study.
    Hing Ling PK; Civeira F; Dan AG; Hanson ME; Massaad R; De Tilleghem Cle B; Milardo C; Triscari J
    Lipids Health Dis; 2012 Jan; 11():18. PubMed ID: 22293030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model.
    Vilahur G; Casani L; Peña E; Juan-Babot O; Mendieta G; Crespo J; Badimon L
    Int J Cardiol; 2014 Aug; 175(3):528-38. PubMed ID: 25023790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.
    Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
    Am J Cardiol; 2003 Mar; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
    Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.
    Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T
    JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals.
    Beck AL; Otto ME; D'Avila LB; Netto FM; Armendaris MK; Sposito AC
    Atherosclerosis; 2012 Jun; 222(2):444-8. PubMed ID: 22554359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
    Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ
    Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia.
    Rodriguez-Porcel M; Lerman A; Ritman EL; Wilson SH; Best PJ; Lerman LO
    Circulation; 2000 Oct; 102(17):2028-30. PubMed ID: 11044415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors on the concentration of insulin-like growth factor-1 (IGF-1) in hypercholesterolemic patients.
    Szkodziński J; Romanowski W; Hudzik B; Kaszuba A; Nowakowska-Zajdel E; Szkilnik R; Pietrasińska B; Zubelewicz-Szkodzińska B
    Pharmacol Rep; 2009; 61(4):654-64. PubMed ID: 19815947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia.
    Zhu XY; Rodriguez-Porcel M; Bentley MD; Chade AR; Sica V; Napoli C; Caplice N; Ritman EL; Lerman A; Lerman LO
    Circulation; 2004 May; 109(17):2109-15. PubMed ID: 15051643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients.
    Wallace CK; Stetson SJ; Küçüker SA; Becker KA; Farmer JA; McRee SC; Koerner MM; Noon GP; Torre-Amione G
    J Heart Lung Transplant; 2005 Jan; 24(1):46-51. PubMed ID: 15653378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia.
    Recto CS; Acosta S; Dobs A
    Clin Cardiol; 2000 Sep; 23(9):682-8. PubMed ID: 11016019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes.
    Rotella CM; Zaninelli A; Le Grazie C; Hanson ME; Gensini GF
    Lipids Health Dis; 2010 Jul; 9():80. PubMed ID: 20663203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
    Baigent C; Landray M; Leaper C; Altmann P; Armitage J; Baxter A; Cairns HS; Collins R; Foley RN; Frighi V; Kourellias K; Ratcliffe PJ; Rogerson M; Scoble JE; Tomson CR; Warwick G; Wheeler DC
    Am J Kidney Dis; 2005 Mar; 45(3):473-84. PubMed ID: 15754269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hempseed (Cannabis sativa) offers effective alternative over statins in ameliorating hypercholesterolemia associated nephropathy.
    Kaur S; Garg A; Kaushal N
    Clin Biochem; 2021 Jul; 93():104-111. PubMed ID: 33861983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term influence of diet and simvastatin on brachial artery endothelial function.
    Jensen LO; Thayssen P; Pedersen KE; Haghfelt T
    Int J Cardiol; 2006 Feb; 107(1):101-6. PubMed ID: 16337504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of simvastatin on coronary flow reserve in patients with atherosclerosis and hypercholesterolemia: an intracoronary Doppler study.
    Jensen LO; Thayssen P; Pedersen KE; Haghfelt T
    Coron Artery Dis; 2006 Feb; 17(1):51-6. PubMed ID: 16374142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.